CC-486
Showing 26 - 50 of 953
Microsatellite Stable Colorectal Carcinoma, Platinum Resistant Epithelial Ovarian Cancer Type II, Estrogen Receptor Positive and
Completed
- Microsatellite Stable Colorectal Carcinoma
- +2 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Mar 30, 2021
Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial in United States (Oral Azacitidine, Rituximab, cyclophosphamide)
Completed
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Follicular
- Oral Azacitidine
- +4 more
-
Tampa, Florida
- +6 more
Aug 26, 2020
Acute Myeloid Leukemia Trial in Japan (Oral Azacitidine, Placebo)
Recruiting
- Acute Myeloid Leukemia
- Oral Azacitidine
- Placebo
-
Nagoya, Aichi, Japan
- +30 more
May 25, 2022
Ann Arbor Stage III DLBCL, Ann Arbor Stage IIX (Bulky) DLBCL, Ann Arbor Stage IV DLBCL Trial in United States (drug, other,
Suspended
- Ann Arbor Stage III Diffuse Large B-Cell Lymphoma
- +20 more
- Cyclophosphamide
- +6 more
-
Tucson, Arizona
- +110 more
Jan 31, 2023
Urinary Bladder Tumors, Carcinoma, Transitional Cell, Ovarian Tumors Trial in Worldwide (CC-486, Carboplatin, ABI-007)
Completed
- Urinary Bladder Neoplasms
- +7 more
- CC-486
- +2 more
-
Scottsdale, Arizona
- +12 more
Nov 7, 2019
Leukemia, Myeloid, Acute Trial in Worldwide (Oral Azacitidine, Placebo)
Active, not recruiting
- Leukemia, Myeloid, Acute
- Oral Azacitidine
- Placebo
-
Phoenix, Arizona
- +247 more
Jan 13, 2023
MDS (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myelogenous Leukemia (AML) Trial in United States (Subcutaneous (SC)
Completed
- Myelodysplastic Syndromes (MDS)
- +2 more
- Subcutaneous (SC) Azacitidine
- Oral Azacitidine
-
Gainesville, Florida
- +17 more
Nov 6, 2019
MDS, Myeloproliferative Chronic Myelomonocytic Leukemia Trial in Houston (Cladribine, Cytarabine, Venetoclax)
Recruiting
- Myelodysplastic Syndromes
- Myeloproliferative Chronic Myelomonocytic Leukemia
- Cladribine
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Oct 31, 2022
Leukemia, Myeloid, Acute, MDS Trial in United Kingdom, United States (CC-486)
Completed
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
- CC-486
-
New York, New York
- +4 more
Oct 22, 2018
Rotator Cuff Tears Trial in Houston (ActiveMatrix® Dosage A, ActiveMatrix® Dosage B, Saline injection)
Not yet recruiting
- Rotator Cuff Tears
- ActiveMatrix® Dosage A
- +2 more
-
Houston, TexasThe University of Texas Health Science Center at Houston
May 30, 2023
Adhesive Capsulitis Trial in Houston (Corticosteroid, ActiveMatrix, Lidocaine)
Recruiting
- Adhesive Capsulitis
- Corticosteroid
- +2 more
-
Houston, TexasThe University of Texas Health Science Center at Houston
Apr 21, 2023
Acute Myeloid Leukemia Trial in Nanjing (Venclexta 100 MG Oral Tablet)
Recruiting
- Acute Myeloid Leukemia
- Venclexta 100 MG Oral Tablet
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital with Nanjing Medical University
Jun 11, 2023
Anal Fistula Trial in Houston (procedure, other, device)
Recruiting
- Anal Fistula
- Surgery
- +2 more
-
Houston, TexasThe University of Texas Health Science Center at Houston
Apr 5, 2023
MDS Trial in Beijing (Lenalidomide, Azacitidine)
Not yet recruiting
- Myelodysplastic Syndromes
-
Beijing, ChinaPeking union medical college hospital
Aug 16, 2023
Acromioclavicular Joint Dislocation Trial in Chon Buri (K-wire)
Recruiting
- Acromioclavicular Joint Dislocation
- K-wire
-
Chon Buri, ThailandQueen Savang Vadhana Memorial Hospital
May 2, 2023
Cervical Cancer Trial (Game Changers for Cervical Cancer Prevention)
Not yet recruiting
- Cervical Cancer
- Game Changers for Cervical Cancer Prevention
- (no location specified)
Aug 17, 2023
Cushing's Disease Trial run by the NINDS (Vorinostat)
Recruiting
- Cushing's Disease
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Resuscitative Thoracotomy Practices
Enrolling by invitation
- Resuscitative Thoracotomy Practices
- Resuscitative thoracotomies
-
Dallas, TexasMethodist Dallas Medical Center
Jul 6, 2023
Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (CC-122, CC-223, Rituximab)
Active, not recruiting
- Lymphoma, Large B-Cell, Diffuse
- CC-122
- +3 more
-
Santa Barbara, California
- +22 more
Jan 25, 2023
Colorectal Cancer Trial (Administration of CC-3)
Not yet recruiting
- Colorectal Cancer
- Administration of CC-3
- (no location specified)
Aug 11, 2023